Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · IEX Real-Time Price · USD
5.48
-0.23 (-4.03%)
At close: Jul 19, 2024, 4:00 PM
5.70
+0.22 (4.01%)
Pre-market: Jul 22, 2024, 7:21 AM EDT
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $463.84 million as of July 22, 2024. Its market cap has decreased by -27.18% in one year.
Market Cap
463.84M
Enterprise Value
324.45M
1-Year Change
-27.18%
Ranking
Category
Stock Price
$5.48
Market Cap Chart
Since January 25, 2007, Anavex Life Sciences's market cap has increased from $59.50M to $463.84M, an increase of 679.56%. That is a compound annual growth rate of 12.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 463.80M | -39.31% |
Dec 29, 2023 | 764.20M | 5.86% |
Dec 30, 2022 | 721.90M | -45.24% |
Dec 31, 2021 | 1.32B | 264.55% |
Dec 31, 2020 | 361.60M | 148.69% |
Dec 31, 2019 | 145.40M | 100.00% |
Dec 31, 2018 | 72.70M | -48.95% |
Dec 29, 2017 | 142.40M | -9.24% |
Dec 30, 2016 | 156.90M | -18.58% |
Dec 31, 2015 | 192.70M | 1,752.88% |
Dec 31, 2014 | 10.40M | 11.83% |
Dec 31, 2013 | 9.30M | -61.09% |
Dec 31, 2012 | 23.90M | -28.01% |
Dec 30, 2011 | 33.20M | -63.79% |
Dec 31, 2010 | 91.70M | 102.88% |
Dec 31, 2009 | 45.20M | -12.23% |
Dec 31, 2008 | 51.50M | -48.91% |
Dec 31, 2007 | 100.80M | 69.41% |
Jan 25, 2007 | 59.50M | - |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
biote | 485.75M |
Third Harmonic Bio | 483.61M |
Cassava Sciences | 483.60M |
Enhabit | 475.98M |
Theravance Biopharma | 465.42M |
MaxCyte | 459.99M |
EyePoint Pharmaceuticals | 458.34M |
Bioventus | 457.64M |